Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Diabetes Care Devices Market Poised To Hit $130.76 Billion By 2030 With A 12.3% CAGR
The diabetes care devices market size has seen significant rapid expansion in recent years. This market is expected to expand from $73.91 billion in 2025 to $82.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. Several factors contributed to this historical growth, including the increasing global prevalence of diabetes, enhanced access to glucose monitoring devices, the expansion of outpatient diabetes care services, greater awareness of self-monitoring practices, and the rising availability of disposable testing supplies.
The diabetes care devices market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $130.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This projected growth can be attributed to a heightened demand for real-time glucose monitoring, the increasing uptake of closed-loop insulin systems, the broadening reach of digital diabetes management platforms, a sharpened emphasis on individualized diabetes care, and increased healthcare investments dedicated to chronic disease management. Key trends during this period are expected to encompass the growing acceptance of continuous glucose monitoring devices, an increase in the utilization of smart insulin delivery systems, the deeper integration of mobile health platforms, the broadening of connected diabetes management ecosystems, and a greater concentration on patient-focused monitoring solutions.
Get A Free Sample Report With In-Depth Market Insights:
Diabetes Care Devices Market Growth Drivers: What’s Behind The Acceleration?
The diabetes care device market is projected to expand in the future, driven by increasing healthcare expenditures. Healthcare expenditures encompass the total amount spent on health-related services, products, and activities over a specific period, typically at an individual, community, national, or global level. This rise in healthcare spending, combined with enhanced access to healthcare services and a growing number of diabetes diagnoses, stimulates increased investments in research and development. This ultimately leads to advancements in diabetes care devices, such as improved glucose monitoring systems, insulin delivery mechanisms, and digital health solutions. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a U.S. federal agency, reported that National Health Expenditure (NHE) grew by 7.5% to $4.9 trillion in 2023, amounting to $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures also rose by 10.4% to $1,519.7 billion in 2023, a faster rate than the 3.2% growth recorded in 2022. Therefore, the continuous increase in healthcare expenditure is anticipated to fuel the growth of the diabetes care device market going forward.
Diabetes Care Devices Market Segment Landscape: Which Areas Lead Development?
The diabetes care devices market covered in this report is segmented –
1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters
2) By Type of Expenditure: Public, Private
3) By Consumable Type: Instruments Or Equipment, Disposables
4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors
2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens
3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes
4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps
5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)
6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters
7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management
Diabetes Care Devices Market Trends: What’s Defining The Industry’s Next Phase?
Leading firms within the diabetes care devices market are prioritizing the creation of sophisticated solutions, including real-time glucose monitoring technology, to elevate precision, user convenience, and proactive disease control. This real-time glucose monitoring system delivers automated, ongoing glucose readings and notifications, empowering individuals with diabetes to make prompt choices and mitigate potential health hazards. An illustrative example is seen in August 2025, when Abbott Laboratories, a healthcare company based in the US, introduced the FreeStyle Libre 2 Plus. This innovation provides continuous, minute-by-minute glucose data transmitted directly to a compatible smartphone, alongside customizable alerts for instances of low or high glucose levels. The device facilitates assured self-management of diabetes by supplying automated alerts, insights into historical trends, and directional indicators, thereby eliminating the need for regular fingerstick tests. Utilizing near-field communication and Bluetooth connectivity, it functions effectively and is designed for wear for a duration of up to 15 days. Furthermore, it permits caregivers to obtain glucose status updates via integrated digital health platforms. This device contributes to enhanced patient safety through facilitating rapid interventions and boosts user engagement by offering real-time data that informs everyday health decisions.
Diabetes Care Devices Market Company Landscape And Competitive Strategy
Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited
View The Full Diabetes Care Devices Market Report:
Diabetes Care Devices Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
